美国信息技术与创新基金会ITIF2024人工智能赋能生物制药行业创新研究报告英文版47页

itif.org Harnessing AI to Accelerate Innovation in the Biopharmaceutical Industry SANDRA BARBOSU | NOVEMBER 2024 AI has the potential to transform drug development by enhancing productivity across the entire development pipeline, boosting biopharmaceutical innovation, accelerating the delivery of new therapies, and fostering competition to help improve public health outcomes. KEY TAKEAWAYS • Drug development is a costly, lengthy, and risky process, marked by declining productivity. Bringing a new drug to market can cost billions of dollars and take over a decade, with fewer than 8 percent of early candidates succeeding. • AI has the potential to boost the efficiency of drug development, accelerating the delivery of new therapies and fostering competition, which could improve public health outcomes. • AI applications span the entire drug development pipeline—from speeding up drug discovery and enhancing clinical trials to streamlining manufacturing and supply chains. • For broader, e